US Patent Issued to FIDIA FARMACEUTICI on July 28 for "Antiviral agents for prevention or treatment of pathologies caused by alpha- and/or beta-coronaviruses" (Italian Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,139, issued on July 28, was assigned to FIDIA FARMACEUTICI S.p.A. (Abano Terme, Italy).

"Antiviral agents for prevention or treatment of pathologies caused by alpha- and/or beta-coronaviruses" was invented by Carlo Pizzocaro (Abano Terme, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Ester and sulfated derivatives of hyaluronic acid are described for use in the prevention and treatment of the initial stage of SARS-CoV-2 disease."

The patent was filed on Dec. 22, 2021, under Application No. 18/268,371.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOF...